Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice.
Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Liu W, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D. Hasanali ZS, et al. Among authors: kadu s. JCI Insight. 2024 May 7;9(10):e177300. doi: 10.1172/jci.insight.177300. JCI Insight. 2024. PMID: 38713510 Free PMC article.
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.
Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D. Hasanali ZS, et al. Among authors: kadu s. bioRxiv [Preprint]. 2024 Jan 24:2024.01.21.576547. doi: 10.1101/2024.01.21.576547. bioRxiv. 2024. Update in: JCI Insight. 2024 May 7;9(10):e177300. doi: 10.1172/jci.insight.177300 PMID: 38328086 Free PMC article. Updated. Preprint.
Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy.
Koppiker CB, Kelkar DA, Kulkarni M, Kadu S, Pai M, Dhar U, Deshmukh C, Varghese B, Zamre V, Jumle N, Gangurde N, Joshi A, Unde R, Banale R, Namewar N, Vaid P, Busheri L, Thomas G, Nare S, Pereira J, Badve S. Koppiker CB, et al. Among authors: kadu s. Front Oncol. 2023 Sep 7;13:1176609. doi: 10.3389/fonc.2023.1176609. eCollection 2023. Front Oncol. 2023. PMID: 37746279 Free PMC article.
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Tang Y, Liu W, Kadu S, Johnson O, Hasanali ZS, Kelly A, Shestov A, Pajarillo R, Greenblatt E, Holmes M, Wang LP, Shih N, O'Connor RS, Ruella M, Garfall AL, Allman D, Vogl DT, Cohen A, June CH, Sheppard NC. Tang Y, et al. Among authors: kadu s. Blood. 2024 Jan 11;143(2):139-151. doi: 10.1182/blood.2022018658. Blood. 2024. PMID: 37616575 Free PMC article.
Therapeutic mammoplasty: a "wise" oncoplastic choice-lessons from the largest single-center cohort from Asia.
Koppiker C, Joshi S, Mishra R, Kelkar DA, Chigurupati P, Joshi A, John J, Kadu S, Bagdia A, Thakkar D, Deshmukh C, Allampati H, Sharan G, Dhar U, Nare S, Nagarkar S, Busheri L, Varghese B, Pai M. Koppiker C, et al. Among authors: kadu s. Front Oncol. 2023 Apr 14;13:1131951. doi: 10.3389/fonc.2023.1131951. eCollection 2023. Front Oncol. 2023. PMID: 37124516 Free PMC article.